In the News


Urine, blood glucose self-monitoring equally effective for new type 2 patients

Patients with newly diagnosed type 2 diabetes had equal improvement in HbA1c whether they self-monitored by testing their blood or urine glucose, a study found.

Mortality rates may differ among sulfonylureas, meta-analysis finds

Among sulfonylureas, gliclazide and glimepiride were associated with a lower risk of all-cause and cardiovascular-related mortality than glyburide, a meta-analysis found.

EMRs could be used to help improve diabetes diagnosis, quality of care

Through accurate coding, electronic medical records (EMRs) may help improve diagnosis of diabetes and quality of care, according to a recent study.

MKSAP Quiz: Kidney testing in a type 2 diabetic

This month's quiz asks readers to evaluate a 67-year-old man following a recent diagnosis of type 2 diabetes mellitus.

Analysis finds several treatments for painful diabetic neuropathy more effective than placebo

A large meta-analysis recently compared the effectiveness of pharmacological treatments for painful diabetic neuropathy.

Random or fasting glucose tests can target diabetes screening after MI

Random or fasting glucose measurements can be used to screen for diabetes in patients admitted for acute myocardial infarction, a study found.

Glucose monitoring system approved specifically for critical care units

The FDA recently approved a new indication for the Nova StatStrip Glucose Hospital Meter System, extending its use to critically ill patients who have been hospitalized.

Combo of metformin and dapagliflozin approved

A once-daily combination pill of dapagliflozin and metformin HCl extended-release (Xigduo XR) was recently approved by the FDA.

Spotlight on metformin

Metformin—including its use, effects, and mechanisms—was the focus of some research published in the past month.

Physician editor: David V. O'Dell, MD, FACP